Skip to main content Deutsch


Michael Leutner
Priv.Doz.Dr. Michael Leutner, MSc PhD

Department of Medicine III (Division of Endocrinology and Metabolism)
Position: Consultant

ORCID: 0000-0003-3959-1496
T +43 1 40400 22290


Diabetes Mellitus; Diabetes, Gestational; Dyslipidemias; Endocrinology; Glucose Metabolism Disorders; Osteoporosis

Research interests

My current research investigates the relationship between cholesterol-lowering drugs such as statins and the development of hormone-related diseases. Statins inhibit HMG-CoA reductase, the main enzyme in the synthesis of cholesterol. Cholesterol is the basic substance for the synthesis of vital hormones such as testosterone or oestrogen. I am therefore currently investigating whether there is a dose-dependent relationship between statins and osteoporosis.

Further research interests are:

  • Endocrinology and metabolism
  • Hyperlipidemia
  • Diabetes mellitus
  • Gender Medicine
  • Gestational diabetes

Techniques, methods & infrastructure

  • Big data
  • Prospective clinical studies
  • Functional tests measuring insulin secretion, insulin sensitivity, beta-cell function and incretins
  • Continuous glucose monitoring
  • Magnetic resonance spectroscopy
  • Intestinal microbiome 

Selected publications

  1. Leutner, M. et al., 2019. Diagnosis of osteoporosis in statin-treated patients is dose-dependent. Annals of the Rheumatic Diseases, 78(12), pp.1706–1711. Available at:
  2. Leutner, M. et al., 2019. A Sex-Specific Analysis of the Predictive Value of Troponin I and T in Patients With and Without Diabetes Mellitus After Successful Coronary Intervention. Frontiers in Endocrinology, 10. Available at:
  3. Leutner, M. et al., 2019. Glucagon-like peptide 1 (GLP-1) drives postprandial hyperinsulinemic hypoglycemia in pregnant women with a history of Roux-en-Y gastric bypass operation. Metabolism, 91, pp.10–17. Available at:
  4. Leutner, M. et al., 2018. Pericardial Fat Relates to Disturbances of Glucose Metabolism in Women with the Polycystic Ovary Syndrome, but Not in Healthy Control Subjects. International Journal of Endocrinology, 2018, pp.1–8. Available at:
  5. Leutner, M. et al., 2016. Clinical and metabolic characteristics of treated hyperlipidemic patients additionally affected by subclinical hyperglycemia. Lipids in Health and Disease, 15(1). Available at: